Literature DB >> 11853081

Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur.

Xinqian Chen1, Louis S Kidder, William D Lew.   

Abstract

The goal of this study was to use a segmental defect model in the rat femur to determine if osteogenic protein-1 (OP-1) is capable of inducing bone formation in the presence of bacterial contamination. A 6 mm segmental defect was surgically created and stabilized with a polyacetyl plate and Kirschner wires in one femur in each of 126 Sprague-Dawley rats. The animals were divided into eight groups in which the defect was either left untreated, or subjected to various combinations of OP-1 (11 or 50 microg), lyophilized bovine type I collagen (carrier for the OP-1), and 10(5) colony-forming units of Staphylococcus aureus. The animals were euthanized at either 2, 4, or 9 weeks. Quantitative radiographic and histologic analyses were performed on the harvested tissue. The initial contamination progressed to infection in all animals receiving bacteria, as determined by qualitative bacteriology. There was very little, if any, bone formation in the untreated defects, and in the contaminated defects with or without collagen carrier. Bone formation was significantly greater in contaminated defects with either dose of OP-1, compared with contaminated defects without OP-1. The 50 microg dose of OP-1 induced significantly more bone formation than the 11 microg dose, both with and without bacteria. This investigation has demonstrated that OP-1 maintains its osteoinductive capability in a contaminated segmental defect. OP-1 may potentially be used in the clinical management of contaminated fractures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853081     DOI: 10.1016/S0736-0266(01)00060-2

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  26 in total

1.  Adjunctive therapies in the treatment of osteomyelitis.

Authors:  Robert C Fang; Robert D Galiano
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

Review 2.  Infected animal models for tissue engineering.

Authors:  Alexander M Tatara; Sarita R Shah; Carissa E Livingston; Antonios G Mikos
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

3.  Bone healing of critical size defects of the rat femur after the application of bone marrow aspirate and two different rh-BMP7 concentrations.

Authors:  F Högel; S Hoffmann; S Hungerer; E Fleischacker; T Ullamann; O B Betz; P Augat
Journal:  Eur J Trauma Emerg Surg       Date:  2014-11-22       Impact factor: 3.693

Review 4.  Growth factor delivery: how surface interactions modulate release in vitro and in vivo.

Authors:  William J King; Paul H Krebsbach
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 5.  Infection and tissue engineering in segmental bone defects--a mini review.

Authors:  Manitha B Nair; James D Kretlow; Antonios G Mikos; F Kurtis Kasper
Journal:  Curr Opin Biotechnol       Date:  2011-02-25       Impact factor: 9.740

6.  A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.

Authors:  Alexander R Vaccaro; Tushar Patel; Jeffrey Fischgrund; D Greg Anderson; Eeric Truumees; Harry Herkowitz; Frank Phillips; Alan Hilibrand; Todd J Albert
Journal:  Eur Spine J       Date:  2005-01-26       Impact factor: 3.134

7.  Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study.

Authors:  Louis S Kidder; Xinqian Chen; Andrew H Schmidt; William D Lew
Journal:  Clin Orthop Relat Res       Date:  2008-07-29       Impact factor: 4.176

8.  Gene therapy to improve osteogenesis in bone lesions with severe soft tissue damage.

Authors:  Tim Rose; Hairong Peng; Arvydas Usas; Ryosuke Kuroda; Helmut Lill; Freddie H Fu; Johnny Huard
Journal:  Langenbecks Arch Surg       Date:  2003-09-20       Impact factor: 3.445

9.  rhBMP-2 modulation of gene expression in infected segmental bone defects.

Authors:  Katherine E Brick; Xinqian Chen; Jamie Lohr; Andrew H Schmidt; Louis S Kidder; William D Lew
Journal:  Clin Orthop Relat Res       Date:  2008-11-19       Impact factor: 4.176

10.  Recombinant human bone morphogenetic protein-7 enhances fracture healing in an ischemic environment.

Authors:  Chuanyong Lu; Zhiqing Xing; Yan-yiu Yu; Celine Colnot; Theodore Miclau; Ralph S Marcucio
Journal:  J Orthop Res       Date:  2010-05       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.